Sansure Biotech Inc. (SHA:688289)
China · Delayed Price · Currency is CNY 20.17
+0.32 (1.61%)
At close: Jan 23, 2026
Sansure Biotech Market Cap
Sansure Biotech has a market cap or net worth of 11.58 billion as of January 23, 2026. Its market cap has decreased by -10.17% in one year.
Market Cap
11.58B
Enterprise Value
8.77B
Revenue
1.67B
Ranking
n/a
PE Ratio
50.05
Stock Price
20.17
Market Cap Chart
Since August 28, 2020, Sansure Biotech's market cap has decreased from 46.42B to 11.58B, a decrease of -75.05%. That is a compound annual growth rate of -22.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 11.58B | 6.66% |
| Dec 31, 2025 | 10.86B | -16.48% |
| Dec 31, 2024 | 13.00B | 16.22% |
| Dec 29, 2023 | 11.19B | -12.24% |
| Dec 30, 2022 | 12.75B | -45.99% |
| Dec 31, 2021 | 23.60B | -48.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Andon Health | 17.28B |
| Micro-Tech (Nanjing) Co.,Ltd | 15.81B |
| Autek China | 14.39B |
| Tofflon Science and Technology Group | 13.20B |
| Eyebright Medical Technology (Beijing) | 11.90B |
| Jiangsu Hualan New Pharmaceutical Material | 11.81B |
| Tinavi Medical Technologies | 10.69B |
| Mingyue Optical Lens | 8.83B |